Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Basal ganglia disease.

× No keyword cloud information.

17 in total

1. Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.

Authors: Stefan Jean-Pierre Haas; Stanislav Petrov; Golo Kronenberg; Oliver Schmitt; Andreas Wree
Journal: J Anat Date: 2007-11-23 Impact factor: 2.610

Review 2. Novel oral drug formulations. Their potential in modulating adverse effects.

Authors: A T Florence; P U Jani
Journal: Drug Saf Date: 1994-03 Impact factor: 5.606

3. Antagonistic but Not Symmetric Regulation of Primary Motor Cortex by Basal Ganglia Direct and Indirect Pathways.

Authors: Ian A Oldenburg; Bernardo L Sabatini
Journal: Neuron Date: 2015-06-03 Impact factor: 17.173

4. Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.

Authors: J Drago; P Padungchaichot; J Y Wong; A J Lawrence; J F McManus; S H Sumarsono; A L Natoli; M Lakso; N Wreford; H Westphal; I Kola; D I Finkelstein
Journal: J Neurosci Date: 1998-12-01 Impact factor: 6.167

5. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Authors: Emilie Lacombe; Carole Carcenac; Sabrina Boulet; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Journal: Eur J Neurosci Date: 2007-09-06 Impact factor: 3.386

6. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.

Authors: F Girotti; F Carella; G Scigliano; M P Grassi; P Soliveri; P Giovannini; E Parati; T Caraceni
Journal: J Neurol Neurosurg Psychiatry Date: 1984-08 Impact factor: 10.154

7. Future of cell and gene therapies for Parkinson's disease.

Authors: Ole Isacson; Jeffrey H Kordower
Journal: Ann Neurol Date: 2008-12 Impact factor: 10.422

Review 8. Nicotinic receptors as CNS targets for Parkinson's disease.

Authors: Maryka Quik; Tanuja Bordia; Kathryn O'Leary
Journal: Biochem Pharmacol Date: 2007-06-17 Impact factor: 5.858

9. Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.

Authors: T A Cawley; T J Shickley; M R Ruggieri; G R Luthin
Journal: J Pharmacol Exp Ther Date: 1993-10 Impact factor: 4.030

Review 10. Dopamine receptor mapping with PET imaging in Parkinson's disease.

Authors: Flavia Niccolini; Paul Su; Marios Politis
Journal: J Neurol Date: 2014-03-15 Impact factor: 4.849